Free Trial

ImmunoPrecise Antibodies (IPA) Short Interest Ratio & Short Volume

ImmunoPrecise Antibodies logo
$0.55 +0.03 (+5.40%)
As of 04:00 PM Eastern

ImmunoPrecise Antibodies Short Interest Data

ImmunoPrecise Antibodies (IPA) has a short interest of 150,000 shares, representing 0.69% of the float (the number of shares available for trading by the public). This marks a -47.00% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 714,203 shares to cover all short positions.

Current Short Interest
150,000 shares
Previous Short Interest
283,000 shares
Change Vs. Previous Month
-47.00%
Dollar Volume Sold Short
$60,491.40
Short Interest Ratio
0.3 Days to Cover
Last Record Date
December 15, 2024
Outstanding Shares
31,062,000 shares
Float Size
21,810,000 shares
Short Percent of Float
0.69%
Today's Trading Volume
601,710 shares
Average Trading Volume
714,203 shares
Today's Volume Vs. Average
84%
Short Selling ImmunoPrecise Antibodies?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for ImmunoPrecise Antibodies and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

IPA Short Interest Over Time

IPA Days to Cover Over Time

IPA Percentage of Float Shorted Over Time

ImmunoPrecise Antibodies Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
12/15/2024150,000 shares $60,491.40 -47.0%0.7%0.3 $0.40
11/30/2024283,000 shares $107,540.00 -58.9%1.3%0.5 $0.38
11/15/2024688,800 shares $306,171.60 +3.4%3.2%1.3 $0.44
10/31/2024666,100 shares $317,729.70 +355.9%3.1%1.4 $0.48
10/15/2024146,100 shares $83,277.00 -19.8%0.7%0.7 $0.57
9/30/2024182,200 shares $116,425.80 +65.9%0.8%1.1 $0.64
9/15/2024109,800 shares $73,566.00 -2.1%0.5%0.9 $0.67
8/31/2024112,100 shares $84,635.50 +16.1%0.5%1.3 $0.76
8/15/202496,600 shares $86,940.00 -4.1%0.5%1.1 $0.90
7/31/2024100,700 shares $79,452.30 -14.4%0.5%1.4 $0.79
7/15/2024117,700 shares $114,992.90 -15.7%0.6%1.6 $0.98
6/30/2024139,600 shares $140,996.00 -8.0%0.7%1.8 $1.01
6/15/2024151,700 shares $159,285.00 -7.8%0.7%1.7 $1.05
5/31/2024164,600 shares $184,352.00 -18.1%0.8%1.3 $1.12
5/15/2024201,000 shares $230,808.30 -35.5%0.9%0.4 $1.15
4/30/2024311,500 shares $392,490.00 -8.4%1.5%0.5 $1.26
4/15/2024340,000 shares $421,600.00 +6.9%1.6%0.6 $1.24
3/31/2024318,200 shares $483,664.00 -27.8%1.5%0.5 $1.52
3/15/2024440,700 shares $634,608.00 +1,290.2%2.0%0.8 $1.44
2/29/202431,700 shares $58,328.00 -37.6%0.2%0.1 $1.84
2/15/202450,800 shares $100,584.00 +232.0%0.2%0.4 $1.98
1/31/202415,300 shares $27,693.00 -38.3%0.1%0.1 $1.81
1/15/202424,800 shares $41,168.00 +31.2%0.1%0.2 $1.66
12/31/202318,900 shares $32,319.00 -34.8%0.1%0.2 $1.71
12/15/202329,000 shares $40,020.00 +2.1%0.1%0.3 $1.38
11/30/202328,400 shares $44,588.00 -2.1%0.1%0.3 $1.57
11/15/202329,000 shares $42,050.00 -38.3%0.1%0.4 $1.45
10/31/202347,000 shares $108,269.20 +99.2%0.2%0.7 $2.30
10/15/202323,600 shares $30,208.00 -48.3%0.1%0.4 $1.28
9/30/202345,600 shares $83,448.00 +2.9%0.2%1 $1.83
9/15/202344,300 shares $77,968.00 -2.0%0.2%1 $1.76
8/31/202345,200 shares $85,428.00 +52.2%0.2%1.1 $1.89
8/15/202329,700 shares $67,315.05 -24.0%0.1%0.8 $2.27
7/31/202339,100 shares $98,532.00 -22.6%0.2%0.5 $2.52
7/15/202350,500 shares $142,410.00 -3.6%0.2%0.6 $2.82
6/30/202352,400 shares $155,104.00 -46.0%0.2%0.6 $2.96
6/15/202397,000 shares $280,330.00 -1.2%0.4%1.1 $2.89
5/31/202398,200 shares $310,312.00 +0.3%0.4%1.1 $3.16
5/15/202397,900 shares $299,574.00 No Change0.4%1.1 $3.06
10/31/2022129,400 shares $643,118.00 -12.5%N/A8 $4.97
10/15/2022147,800 shares $691,704.00 +41.8%N/A9 $4.68
9/30/2022104,200 shares $415,758.00 +17.6%N/A6.4 $3.99
9/15/202288,600 shares $430,596.00 -19.3%N/A5.6 $4.86
8/31/2022109,800 shares $585,234.00 -29.8%N/A7.4 $5.33
8/15/2022156,400 shares $828,920.00 -16.4%1.0%9.7 $5.30
7/31/2022187,100 shares $791,433.00 -6.7%1.1%11.7 $4.23
7/15/2022200,600 shares $762,280.00 -9.1%1.2%12.7 $3.80
6/30/2022220,600 shares $838,280.00 -4.8%1.3%10.5 $3.80
6/15/2022231,700 shares $919,849.00 -3.8%1.4%9.2 $3.97
5/31/2022240,800 shares $1.38 million +6.2%1.5%8.1 $5.73
5/15/2022226,800 shares $1.01 million -22.1%1.4%7.4 $4.45
4/30/2022291,300 shares $1.62 million -0.2%1.8%8.5 $5.56
4/15/2022291,900 shares $1.67 million +3.4%1.8%7.8 $5.72
3/31/2022282,200 shares $1.45 million +2.2%N/A0 $5.14
3/15/2022276,200 shares $1.09 million +0.2%1.6%7.5 $3.95
2/28/2022275,600 shares $1.36 million -16.8%1.6%7.5 $4.93
2/15/2022331,400 shares $1.70 million +21.8%1.9%7 $5.13
1/31/2022272,000 shares $1.68 million +16.5%1.6%5.7 $6.18
1/15/2022233,500 shares $1.46 million -24.8%N/A0 $6.26
12/31/2021310,300 shares $1.66 million -12.4%1.8%6 $5.36
12/15/2021354,200 shares $1.91 million +11.2%2.1%5.6 $5.38
11/30/2021318,500 shares $1.91 million +8.9%1.9%4.5 $6.00
11/15/2021292,500 shares $1.78 million -15.0%1.7%3.5 $6.10
10/29/2021344,200 shares $2.26 million -24.2%2.0%2.9 $6.57
10/15/2021454,100 shares $2.99 million +1.3%2.6%2.1 $6.58
9/30/2021448,200 shares $2.79 million -18.3%2.6%0.2 $6.22
9/15/2021548,800 shares $3.62 million -3.1%3.2%0.2 $6.60
8/31/2021566,400 shares $4.18 million -17.1%3.3%0.2 $7.38
8/13/2021682,800 shares $4.81 million +6.9%4.0%0.3 $7.05
7/30/2021638,500 shares $4.20 million +467.6%3.7%0.3 $6.58
7/15/2021112,500 shares $619,875.00 -23.5%0.7%0.1 $5.51
6/30/2021147,000 shares $884,940.00 +18.2%0.9%2.5 $6.02
6/15/2021124,400 shares $931,756.00 -8.0%0.8%1.7 $7.49
5/28/2021135,200 shares $1.06 million +42.3%0.8%1.7 $7.82
5/14/202195,000 shares $712,500.00 +11.8%0.6%1.2 $7.50
4/30/202185,000 shares $878,900.00 +2.8%0.5%0.9 $10.34
4/15/202182,700 shares $904,738.00 +386.5%N/A0 $10.94
3/31/202117,000 shares $150,280.00 +27.8%0.1%0.1 $8.84
3/15/202113,300 shares $153,083.00 -19.9%0.1%0.1 $11.51
2/26/202116,600 shares $222,108.00 +238.8%0.1%0.2 $13.38
2/12/20214,900 shares $68,845.00 -58.5%0.0%0.1 $14.05
1/29/202111,800 shares $200,600.00 +1,375.0%0.1%0.2 $17.00
1/15/2021800 shares $11,992.00 No Change0.0%0 $14.99

IPA Short Interest - Frequently Asked Questions

What is ImmunoPrecise Antibodies' current short interest?

Short interest is the volume of ImmunoPrecise Antibodies shares that have been sold short but have not yet been covered or closed out. As of December 15th, traders have sold 150,000 shares of IPA short. 0.69% of ImmunoPrecise Antibodies' shares are currently sold short. Learn More on ImmunoPrecise Antibodies' current short interest.

What is a good short interest percentage for ImmunoPrecise Antibodies?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.69% of ImmunoPrecise Antibodies' floating shares are currently sold short.

Is ImmunoPrecise Antibodies' short interest increasing or decreasing?

ImmunoPrecise Antibodies saw a decrease in short interest in December. As of December 15th, there was short interest totaling 150,000 shares, a decrease of 47.0% from the previous total of 283,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is ImmunoPrecise Antibodies' float size?

ImmunoPrecise Antibodies currently has issued a total of 31,062,000 shares. Some of ImmunoPrecise Antibodies' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ImmunoPrecise Antibodies currently has a public float of 21,810,000 shares.

How does ImmunoPrecise Antibodies' short interest compare to its competitors?

0.69% of ImmunoPrecise Antibodies' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to ImmunoPrecise Antibodies: Aileron Therapeutics, Inc. (0.57%), Kezar Life Sciences, Inc. (0.76%), Iterum Therapeutics plc (8.45%), Achilles Therapeutics plc (0.24%), VYNE Therapeutics Inc. (0.49%), CASI Pharmaceuticals, Inc. (1.11%), Celularity Inc. (3.36%), Estrella Immunopharma, Inc. (0.14%), vTv Therapeutics Inc. (1.14%), Omega Therapeutics, Inc. (28.30%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.32 billion), Spotify Technology S.A. ($4.06 billion), Canadian Natural Resources Limited ($3.45 billion), Reddit, Inc. ($2.79 billion), International Paper ($2.70 billion), Cencora, Inc. ($2.27 billion), SoFi Technologies, Inc. ($2.21 billion), Lululemon Athletica Inc. ($2.13 billion), and Rivian Automotive, Inc. ($2.05 billion). View all of the most shorted stocks.

What does it mean to sell short ImmunoPrecise Antibodies stock?

Short selling IPA is an investing strategy that aims to generate trading profit from ImmunoPrecise Antibodies as its price is falling. IPA shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against ImmunoPrecise Antibodies?

A short squeeze for ImmunoPrecise Antibodies occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IPA, which in turn drives the price of the stock up even further.

How often is ImmunoPrecise Antibodies' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IPA, twice per month. The most recent reporting period available is December, 15 2024.




This page (NASDAQ:IPA) was last updated on 1/6/2025 by MarketBeat.com Staff
From Our Partners